Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity

Brain Research

Volumn 887, Issue 1, 2000, Pages 110-117

  Fornai, Francesco ^a,b   Battaglia, Giuseppe ^b   Gesi, Marco ^a   Giorgi, Filippo S ^a   Orzi, Francesco ^b,c   Nicoletti, Ferdinando ^b   Ruggieri, Stefano ^b,c  

^a UNIVERSITY OF PISA   (Italy)

^b IRCCS NEUROMED   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

DAT; Experimental parkinsonism; L DOPA; MPTP; Recovery

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE TRANSPORTER; LEVODOPA; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; DOSE RESPONSE; DRUG BRAIN LEVEL; DRUG EFFECT; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OLFACTORY BULB; PARKINSON DISEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; TIME;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LEVODOPA; MALE; MICE; MICE, INBRED C57BL; OLFACTORY BULB; TIME FACTORS;

EID: 0034704291     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02999-1     Document Type: Article

References (40)

1. Hyperactivity of remaining dopaminergic neurons after partial destruction of the nigrostriatal dopaminergic system in the rat
2. Levodopa: Is toxicity a myth?
3. Age-related susceptibility to MPTP-induced neurotoxicity in mice
4. Does levodopa aggravate Parkinson's disease?
5. Suppressive effect of L-DOPA on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine
6. L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion
7. The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53
8. MPP(+)-induced neurotoxicity in mouse is age-dependent: Enhanced by the selective inhibition of complexes of electron transport
9. Absence of neurotoxicity of chronic L-DOPA treatment in 6-hydroxydopamine lesioned rats
10. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injections
11. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions
12. Effects of pretreatment with DSP-4 on methamphetamine-induced striatal dopamine losses and pharmacokinetics
13. Striatal dopamine metabolism in monoamine oxidase B-deficient mice: A brain dialysis study
14. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration
15. Oxidative pathway for catecholamines in the genesis of neuromelanin and cytotoxic quinones
16. L-DOPA up-regulates glutathion and protects mesencephalic cultures against oxidative stress
17. Long-term administration of levodopa does not damage dopaminergic neurons in the mouse
18. L-DOPA in the 1960s: Starting point Vienna
19. Levodopa neurotoxicity: Experimental studies versus clinical relevance
20. Protein measurement with the Folin phenol reagent
21. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: Studies in an animal model
22. Neurotoxicity of levodopa on catecholamine-rich neurons
23. Levodopa toxicity in foetal rat midbrain neurons in culture
24. Glia conditioned medium protects fetal rat midbrain neurones in culture from L-dopa toxicity
25. Chronic Levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery in rats with moderate nigrostriatal lesions
26. Toxic and protective effects of L-DOPA on mesencephalic cell cultures
27. Neurotoxic and neuroprotective actions of catecholamines in cortical neurons
28. Differential effects of chronic L-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-OHDA
29. Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich neuroblastoma cell line
30. Toxic effects of L-dopa on mesencephalic cell cultures: Protection with antioxidants
31. Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronicallly
32. Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 g) plus decarboxylase inhibitor over a four year period
33. Is levodopa toxic to human substantia nigra?
34. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys
35. Neurotoxicity of methamphetamine and related drugs
36. Enhancement of cytotoxicity and clastogenicity of L-DOPA and dopamine by manganese and copper
37. L-DOPA increases nigral production of hydroxyl radicals in vivo: Potential L-DOPA toxicity?
38. Neurochemical responses to 6-OH-DA and L-DOPA therapy: Implications for Parkinson's disease
39. Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - A possible novel pathogenetic mechanism in Parkinson's disease
40. Long-term levoDOPA in Parkinson's disease